Cancer genomic analysis using 13 multidimensional prostate cancer data sets (Figure 5C) showed that significantly higher genetic alterations were observed for AR (19%) and MCL1 (5%) genes among the CGS. This evidence concerns the gene MCL1 and prostate carcinoma.